LianBio
ClosedLianBio is a biotech company in Shanghai, China, founded in 2020. It has raised $313.0M across 2 rounds, most recently a $310.0M Growth Equity in October 2020.
- Headquarters
- Shanghai
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- lianbio.com
- Total Funding
- $313.0M
- Last Round
- $310.0M Growth EquityOct 2020
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
LianBio was a Shanghai-based biotechnology company launched in 2020 by Perceptive Advisors to license and commercialize innovative therapies for patients in China and major Asian markets. The company went public on Nasdaq in 2021 but announced a wind-down of operations following a strategic review completed in February 2024.
Summary
It lists 51–200 employees. It has raised $313.0M in total across 2 rounds, most recently a $310.0M Growth Equity round in Oct 2020. Investors include RA Capital Management, Venrock and Pfizer Ventures.
Funding History
Oct 2020
Sign up to see all 2 events
Funding: Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lianbio"><img src="https://indexed.vc/api/badge/company/lianbio" alt="LianBio on Indexed.vc" width="260" height="76" /></a>